 Isolated rat hepatocytes convert 2,5-anhydromannitol 2,5-anhydromannitol-1-P 2,5-anhydromannitol-1,6-P2. Cellular concentrations monophosphate bisphosphate proportional concentration 2,5-anhydromannitol decreased gluconeogenic substrates glucose. Rat liver phosphofructokinase-1 phosphorylates 2,5-anhydromannitol-1-P; rate less fructose-6-P stimulated fructose-2,6-P2. 1 mM fructose-6-P, bisphosphate compounds activate rat liver phosphofructokinase-1 following order effectiveness: fructose-2,6-P2 much greater 2,5-anhydromannitol-1,6-P2 greater fructose-1,6-P2 greater 2,5-anhydroglucitol-1,6-P2. High concentrations fructose-1,6-P2 2,5-anhydromannitol-1,6-P2 inhibit phosphofructokinase-1. Rat liver fructose 1,6-bisphosphatase inhibited competitively 2,5-anhydromannitol-1,6-P2 noncompetitively 2,5-anhydroglucitol-1,6-P2. AMP inhibition fructose 1,6-bisphosphatase potentiated 2,5-anhydroglucitol-1,6-P2 2,5-anhydromannitol-1,6-P2. Rat liver pyruvate kinase stimulated micromolar concentrations 2,5-anhydromannitol-1,6-P2; maximal activation fructose-1,6-P2. 2,5-Anhydroglucitol-1,6-P2 weak activator. 2,5-Anhydromannitol-1-P stimulates pyruvate kinase effectively fructose-1-P. Effects glucagon pyruvate kinase altered prior treatment hepatocytes 2,5-anhydromannitol. Pyruvate kinase glucagon-treated hepatocytes activity control pyruvate kinase saturating concentrations 2,5-anhydromannitol-1,6-P2 decreased affinity 2,5-anhydromannitol-1,6-P2 stimulated 2,5-anhydromannitol-1-P. inhibition gluconeogenesis enhancement glycolysis gluconeogenic precursors hepatocytes treated 2,5-anhydromannitol explained inhibition fructose 1,6-bisphosphatase, activation pyruvate kinase, abolition influence phosphorylation pyruvate kinase.